CASI Pharmaceuticals Inc (NASDAQ: CASI) stock enjoyed a major increase of 11.7% on 12/6/23. The shares closed at $6.66. Moreover, trading volume in this advance was exceptionally high at 327% of normal. The stock has risen 35.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CASI is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
CASI Pharmaceuticals has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CASI Pharmaceuticals has a very low Appreciation Score of 13 but a very high Power Rating of 88, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment